| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 19, 2010PICTURE Registry Results Published Online Today in EP-Europace
MINNEAPOLIS, Nov 19, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the publication of data showing that use of its Reveal(R) family of Insertable Cardiac Monitors led to...
-
Nov 19, 2010Initial Results from U.S. IDE Study Demonstrate Early Safety and Effectiveness of Implantable Medical Device for Minimally Invasive Treatment of Thoracic Aortic Aneurysms
MINNEAPOLIS & NEW YORK, Nov 19, 2010 (BUSINESS WIRE) -- An implantable medical device used in the minimally invasive treatment of thoracic aortic aneurysms,the Valiant(R) Thoracic Stent Graft...
-
Nov 18, 2010Tricuspid Annuloplasty Ring is Designed to Adapt to the Heart's Natural Tricuspid Valve Acquired Through ATS Medical, New Ring Enhances Medtronic's Surgical Heart Valve Repair Portfolio
MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch and first clinical use of the Tri-Ad(TM) Semi-Flexible Tricuspid Annuloplasty Ring for...
-
Nov 17, 2010New Offering Improves Pre-Case Planning, Procedural Efficiency and Patient Follow-Up
MINNEAPOLIS, Nov 17, 2010 (BUSINESS WIRE) -- Improving the efficiency of endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), today introduced EVARpro(R), a suite of value-added...
-
Nov 16, 2010Acquisition Expands Product Offering and Pipeline for Biologics Business
MEMPHIS, Tenn., Nov 16, 2010 (BUSINESS WIRE) -- Moving to expand its Biologics product offerings, Medtronic, Inc. (NYSE: MDT), announced today it has completed the acquisition of Osteotech,...